Molecular modelling and dynamic simulation of UDP-N-acetylglucosamine 1-carboxyvinyltransferase (MurA) from Mycobacterium tuberculosis using in silico approach

Jothieswari, 2015, Molecular Docking studies of potential chemical inhibitors on multi-drug resistance genes in MTB, Int J Innovat Drug Discov, 5, 40 Moraes, 2015, Structural and functional features of enzymes of MTB peptidoglycan biosynthesis as targets for drug development, Tuberculosis, 95, 95, 10.1016/j.tube.2015.01.006 Akhtar, 2015, Analyzing different acetyl Co-A metabolizing enzymes as potential drug targets against, MTB. British Microbiology Research Journal, 10, 1, 10.9734/BMRJ/2015/19032 Herrmann, 1995, The shikimate pathway: early steps in the biosynthesis of aromatic compounds, Plant Cell, 7, 907, 10.2307/3870046 Barreteau, 2008, Cytoplasmic steps of peptidoglycan biosynthesis, FEMS Microbiol Rev, 32, 168, 10.1111/j.1574-6976.2008.00104.x Basavannacharya, 2010, ATP-dependent MurE ligase in MTB: biochemical and structural characterization, Tuberculosis, 90, 16, 10.1016/j.tube.2009.10.007 Lamichhane, 2011, Essential metabolites of MTB and their mimics, mBio, 2, e00301, 10.1128/mBio.00301-10 Walsh, 1996, The versatility of phosphoenolpyruvate and its vinyl ether products in biosynthesis, Chem Biol, 3, 83, 10.1016/S1074-5521(96)90282-3 Kahan, 1974, The mechanism of action of fosfomycin (phosphonomycin), Ann N Y Acad Sci, 235, 364, 10.1111/j.1749-6632.1974.tb43277.x Kim, 1996, Characterization of a Cys115 to Asp substitution in the Escherichia coli cell wall biosynthetic enzyme UDP-GlcNAc enolpyruvyl transferase (MurA) that confers resistance to inactivation by the antibiotic fosfomycin, Biochem., 35, 4923, 10.1021/bi952937w Zhu, 2012, The functional consequence of covalent reaction of phosphoenolpyruvate with UDP-N-acetylglucosamine 1-carboxyvinyltransferase (MurA), J Biol Chem, 287, 12657, 10.1074/jbc.M112.342725 Altschul, 1997, Gapped BLAST and PSI-BLAST: a new generation of protein database search programs, Nucleic Acids Res, 25, 3389, 10.1093/nar/25.17.3389 Thompson, 1994, CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice, Nucleic Acids Res, 22, 4673, 10.1093/nar/22.22.4673 Pieper, 2011, ModBase, a database of annotated comparative protein structure models, and associated resources, Nucleic Acids Res, 39, D465, 10.1093/nar/gkq1091 Eswar, 2006, Comparative protein structure modelling using modeller, Curr Protoc. Bioinformatics, 10.1002/0471250953.bi0506s15 Case, 2010, 1 Zhang, 2005, Expression, purification and properties of shikimate dehydrogenase from MTB, J Biochem Mol Biol, 38, 624 Colovos, 1993, Verification of protein structures: patterns of nonbonded atomic interactions, Protein Sci, 2, 1511, 10.1002/pro.5560020916 Lüthy, 1992, Assessment of protein models with three-dimensional profiles, Nature, 356, 83, 10.1038/356083a0 Mukherjee, 2013, Rapid identification of hit molecules for target proteins via physicochemical descriptors, Phys Chem Chem Phys, 15, 9107, 10.1039/c3cp44697b Morris, 1998, Automated docking using a Lamarckian genetic algorithm and an empirical binding free energy function, J Comput Chem, 19, 1639, 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B La Motta, 2007, Pyrido [1, 2-a] pyrimidine-4-one derivatives as a novel class of selective aldose reductase inhibitors exhibiting antioxidant activity, J Med Chem, 50, 4917, 10.1021/jm070398a DeLano, 2002, vol. 452 Laskowski, 2011 Wallace, 1996, Derivation of 3D coordinate templates for searching structural databases: application to Ser-His-Asp catalytic triads in the serine proteinases and lipases, Protein Sci, 5, 1001, 10.1002/pro.5560050603 Cheng, 2012 Lipinski, 2001, Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings1, Adv Drug Deliv Rev, 46, 3, 10.1016/S0169-409X(00)00129-0 Veber, 2002, Molecular properties that influence the oral bioavailability of drug candidates, J Med Chem, 45, 2615, 10.1021/jm020017n Ghasemi, 2016, In silico designing of hyper-glycosylated analogs for the human coagulation factor IX, J Mol Graph Model, 68, 39, 10.1016/j.jmgm.2016.05.011 Ramachandran, 2011, Automated minimization of steric clashes in protein structures, Proteins: Structure, Function, and Bioinformatics, 79, 261, 10.1002/prot.22879 Skarzynski, 1998, Stereochemical course of enzymatic enolpyruvyl transfer and catalytic conformation of the active site revealed by the crystal structure of the fluorinated analog of the reaction tetrahedral intermediate bound to the active site of the C115A mutant of MurA, Biochem., 37, 2572, 10.1021/bi9722608